Get the Stockscreener App
4.25
3.16%
0.13
After Hours:
4.16
-0.09
-2.12%
Collplant Biotechnologies Ltd stock is traded at $4.25, with a volume of 24,143.
It is up +3.16% in the last 24 hours and up +1,366% over the past month.
CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives majority revenue, Canada, Europe and Other, and Israel.
See More
Previous Close:
$4.12
Open:
$4.1
24h Volume:
24,143
Relative Volume:
0.01
Market Cap:
$8.04M
Revenue:
$389.00K
Net Income/Loss:
$-13.13M
P/E Ratio:
-4.117
EPS:
-1.0323
Net Cash Flow:
$-11.90M
1W Performance:
-6.80%
1M Performance:
+1,366%
6M Performance:
+466.52%
1Y Performance:
+50.18%
1-Day Range:
$4.03
$4.2901
1-Week Range:
$3.62
$4.60
52-Week Range:
$0.2637
$4.78
Collplant Biotechnologies Ltd Stock (CLGN) Company Profile
Name
Collplant Biotechnologies Ltd
Sector
Industry
Phone
-
Address
-
Compare CLGN vs VRTX, REGN, MRNA, ARGX, RVMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CLGN
Collplant Biotechnologies Ltd
|
4.25 | 8.04M | 389.00K | -13.13M | -11.90M | -1.0323 |
VRTX
Vertex Pharmaceuticals Inc
|
526.19 | 133.37B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
788.04 | 81.13B | 14.92B | 4.42B | 3.79B | 41.04 |
MRNA
Moderna Inc
|
198.88 | 79.40B | 2.23B | -3.19B | -1.60B | -8.1462 |
ARGX
Argen X Se Adr
|
959.49 | 60.03B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
204.97 | 43.93B | 742.00K | -1.37B | -1.07B | -7.0731 |
Collplant Biotechnologies Ltd Stock (CLGN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-17-23 | Initiated | Alliance Global Partners | Buy |
Collplant Biotechnologies Ltd Stock (CLGN) Latest News
What's Behind CollPlant Biotechnologies Ltd.'s (CLGN) Big Moment in Penny Stocks? - Kalkine Media
CollPlant’s LightSolver Reports Major Photonic Computing Breakthrough in HPC Study - tipranks.com
About 40× faster was the low end projected in CollPlant (CLGN) research using a processor emulator. - Stock Titan
How Did CollPlant (NASDAQ:CLGN) Regain Nasdaq Compliance? - Kalkine Media
LightSolver, a CollPlant Company, and HLRS Joint Research Demonstrated Photonic Computing Can significantly Accelerate Fundamental HPC Workloads - PR Newswire
CollPlant Biotechnologies Ltd. (CLGN) stock price, news, quote and history - Yahoo Finance UK
Collplant Biotechnologies Ltd (CLGN) Risk Assessment: Volatility, Financial Risk & Investment Risk - tradingkey.com
CollPlant Biotechnologies Ltd. (CLGN) Stock Price, News, Quote & History - Yahoo! Finance Canada
CollPlant Regains Nasdaq Bid Price Compliance, Shoring Up Dual Tech Strategy - tipranks.com
Nasdaq confirms CollPlant (NASDAQ: CLGN) back over its $1 minimum bid - Stock Titan
CollPlant regains Nasdaq compliance on minimum bid price By Investing.com - Investing.com Canada
CollPlant regains Nasdaq compliance on minimum bid price - Investing.com
Nasdaq confirms CollPlant meets listing rules a... - Pluang
CollPlant Regains Compliance with Nasdaq Minimum Bid Price Requirement - PR Newswire
CollPlant Highlights LightSolver Optical Computing Strategy in Updated September 2026 Presentation - The Globe and Mail
CollPlant Biotechnologies Ltd. (CLGN) Discusses Acquisition of Lightsolver and Strategic Entry Into High-Performance Photonic ComputingSlideshow (NASDAQ:CLGN) 2026-09-18 - Seeking Alpha
CollPlant (NASDAQ: CLGN) backs optical computer it claims is 10,000x faster than GPUs - Stock Titan
CLGN: Disruptive all-optical computing platform targets $89B HPC market with milestone-driven growth - TradingView
CollPlant Launches BioFlex as Recombinant Collagen Broadens - openPR.com
CollPlant expands into photonic computing with LightSolver acquisition and investor webinar set for Sept 17. - Pluang
A new kind of computer uses light to calculate. LightSolver will explain it Sept. 17. - Stock Titan
CollPlant to Host LightSolver Investor Webinar on September 17, 2026 - PR Newswire
CollPlant (NASDAQ: CLGN) gives CFO 510,372 RSUs with 5-year vesting - Stock Titan
COLLPLANT APPOINTS DR. RUTI BEN SHLOMI TO ITS BOARD OF DIRECTORS FOLLOWING CLOSING OF LIGHTSOLVER ACQUISITION - marketscreener.com
CollPlant Adds LightSolver Founder to Board After Closing Photonic Computing Acquisition - The Globe and Mail
CollPlant Biotechnologies LtdADR Key Financial Ratios – Valuation, Profitability & More - Value Research
Biotech CollPlant (CLGN) extends into photonic computing with LightSolver board move - Stock Titan
CollPlant adds LightSolver CEO Dr. Ruti Ben Shl... - Pluang
A physicist who helped create light-based computing joins CollPlant's board - stocktitan.net
CollPlant Finalizes LightSolver Acquisition with $5 Million Equity Investment - Kalkine Media
CollPlant (CLGN) moves into photonic computing with LightSolver acquisition - Stock Titan
CLGN Looks 14.7% Overvalued on GF Value™ - GuruFocus
collplant completes acquisition of lightsolver, entering the photonic computing sector - Fidelity Investments
COLLPLANT COMPLETES ACQUISITION OF LIGHTSOLVER, ENTERING THE PHOTONIC COMPUTING SECTOR - Yahoo Finance
CollPlant Biotechnologies acquires laser-based computing startup LightSolver - Data Center Dynamics
CollPlant to Implement 1-for-10 Reverse Stock Split - marketscreener.com
CLGN Looks 24.2% Overvalued on GF Value™ - GuruFocus
Reverse split ahead for CollPlant (NASDAQ: CLGN) to help keep its Nasdaq listing - Stock Titan
COLLPLANT ANNOUNCES REVERSE SHARE SPLIT - PR Newswire
CollPlant to acquire LightSolver in photonic computing deal - Engineering.com
CollPlant Buys LightSolver in Bet on Laser-Based Computing - finance.biggo.com
CollPlant Biotechnologies Ltd. signed a definitive agreement to acquire Lightsolver Ltd. for $84.2 million. - marketscreener.com
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
CollPlant agrees LightSolver photonic computing deal - grafa.com
Why CollPlant Biotechnologies (CLGN) Stock Is Up Today - Quiver Quantitative
CollPlant Acquires LightSolver, Enters Supercomputing and Photonic Computing Markets - HPCwire
CollPlant to Acquire LightSolver, Pivoting Into Photonic Supercomputing - TipRanks
COLLPLANT IS ACQUIRING LIGHTSOLVER- ENTERS SUPERCOMPUTING AND PH - GuruFocus
CollPlant Biotechnologies (NASDAQ: CLGN) files foreign issuer update - Stock Titan
CollPlant To Acquire LightSolver As Laser Processing Unit Targets 2028 Commercial Launch - Pulse 2.0
CLGN Looks 14.5% Overvalued on GF Value™ - GuruFocus
Collplant Biotechnologies Ltd Stock (CLGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.06%
2.55%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):